Veloxity Labs

@VeloxityL acquired the @SCIEXnews ZenoTOF 8600 system—the first U.S. bioanalytical CRO to do so! See us at #AAPS & #ACT.
👉 veloxitylabs.com/contact | sciex.com
#GLP1 #MassSpec #LCMS

bit.ly/3LePrcS

“Speed with purpose” isn’t a slogan—it’s a system.
Co-authored with sponsor/industry veteran Andy Vick, PhD, our latest report maps practical ways to cut weeks from Discovery → GLP → Clinical.
Read now: bit.ly/4ha32Oc
#Pharma #Bioanalysis #ICHM10

Selectivity. Sensitivity. Throughput. Validation.

See how @VeloxityL peptide-savvy LC–MS/MS delivers early-phase decisions on time.
veloxitylabs.com/modalities/

#PeptideBioanalysis #GLP1 #LCMS #ICHM10

Still using ELISAs for peptide bioanalysis?
LC-MS has advanced and it’s now the smarter choice.

✅ No critical reagents needed
✅ Less cross-reactivity, more multiplexing
✅ Wider linear range

DM us to talk peptide therapeutic development. veloxitylabs.com/contact/

#LCMS

Most CROs patchwork systems together. We built our own.

VELO is @VeloxityL custom lab operations backbone — delivering speed, quality & transparency in every project.

New report: veloxitylabs.com/report-velo-a-…

#Bioanalysis #LCMS